Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5935/1678-9741.20160069 http://scihub22266oqcxt.onion/10.5935/1678-9741.20160069 C5094421!5094421!27849301     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Braz+J+Cardiovasc+Surg 2016 ; 31 (4): 291-9 Nephropedia Template TP {{tp|p=27849301|t=2016. Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia |pdf=|usr=}}{{27849301}} gab.com Text Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia JO: Braz J Cardiovasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=27849301 #FOAvip Objective: Intimal hyperplasia is associated with graft failure and vascular sutures in the first year after surgery and in postangioplasty restenosis. Allium sativum (common garlic) lowers cholesterol and has antioxidant effects; it also has antiplatelet and antitumor properties and, therefore, has great potential to reduce or inhibit intimal hyperplasia of the arteries. Our objective is to determine if the garlic has an efficacy to inhibit myointimal hyperplasia compared to cilostazol. Methods: Female New Zealand rabbits were divided into the following groups (n=10 each) according to treatment: group A, garlic, 800 µg×kg-1×day-1, orally; group C, cilostazol, 50 mg.day-1, orally; group PS, 10 ml of 0.9% physiological saline solution, orally. Our primary is the difference of the mean of myointimal hyperplasia. Statistical analysis was performed by using ANOVA and Tukey tests, as well as the Chi-square test. We calculated the 95% confidence interval for each point estimate, and the P value was set as < 0.05. Results: Group PS had a mean hyperplasia rate of 35.74% (95% CI, 31.76?39.71%); group C, 16.21% (95% CI, 13.36?19.05%); and group A, 21.12% (95% CI, 17.26?25.01%); P<0.0001. Conclusion: We conclude that Allium sativum had the same efficacy in inhibiting myointimal hyperplasia when compared to the positive control, cilostazol. Twit Text FOAVip Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia ????Braz J Cardiovasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=27849301 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27849301 #FOAvip English Wikipedia <ref>{{Cite pmid|27849301}}</ref> Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia #MMPMID27849301 Lima PRda S; Bandeira FCV; Rolim JC; Nogueira MRS; Pordeus MAA; de Oliveira AFB; Pitta GBB Braz J Cardiovasc Surg 2016[Jul]; 31 (4): 291-9 PMID27849301show ga Objective: Intimal hyperplasia is associated with graft failure and vascular sutures in the first year after surgery and in postangioplasty restenosis. Allium sativum (common garlic) lowers cholesterol and has antioxidant effects; it also has antiplatelet and antitumor properties and, therefore, has great potential to reduce or inhibit intimal hyperplasia of the arteries. Our objective is to determine if the garlic has an efficacy to inhibit myointimal hyperplasia compared to cilostazol. Methods: Female New Zealand rabbits were divided into the following groups (n=10 each) according to treatment: group A, garlic, 800 µg×kg-1×day-1, orally; group C, cilostazol, 50 mg.day-1, orally; group PS, 10 ml of 0.9% physiological saline solution, orally. Our primary is the difference of the mean of myointimal hyperplasia. Statistical analysis was performed by using ANOVA and Tukey tests, as well as the Chi-square test. We calculated the 95% confidence interval for each point estimate, and the P value was set as < 0.05. Results: Group PS had a mean hyperplasia rate of 35.74% (95% CI, 31.76?39.71%); group C, 16.21% (95% CI, 13.36?19.05%); and group A, 21.12% (95% CI, 17.26?25.01%); P<0.0001. Conclusion: We conclude that Allium sativum had the same efficacy in inhibiting myointimal hyperplasia when compared to the positive control, cilostazol. äAllium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hy(epmc).pdf DeepDyve Pubget Overpricing